Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("TAUROLIDINE")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 79

  • Page / 4

Export

Selection :

  • and

Taurolidine and oxidative stress: a rationale for local treatment of mesotheliomaACETO, N; BERTINO, P; BARBONE, D et al.The European respiratory journal. 2009, Vol 34, Num 6, pp 1399-1407, issn 0903-1936, 9 p.Article

The effect of taurolidine on experimental thrombus formationKAPTANOGLU, Levent; KUCUK, Hasan Fehmi; COLAK, Elif et al.European journal of pharmacology. 2008, Vol 578, Num 2-3, pp 238-241, issn 0014-2999, 4 p.Article

Preventing Catheter-Related Bacteremia with Taurolidine-Citrate Catheter Locks: A Systematic Review and Meta-AnalysisHONGBO LIU; HONGMEI LIU; JING DENG et al.Blood purification. 2014, Vol 37, Num 3, pp 179-187, issn 0253-5068, 9 p.Article

Taurolidine: mode of administration in mouse tumor modelsBRAUMANN, C; PFIRRMANN, R. W.International journal of cancer (Print). 2012, Vol 131, Num 11, pp 2719-2720, issn 0020-7136, 2 p.Article

The effects of taurolidine, a novel antineoplastic agent, on human malignant mesotheliomaNICI, Linda; MONFILS, Barbara; CALABRESI, Paul et al.Clinical cancer research. 2004, Vol 10, Num 22, pp 7655-7661, issn 1078-0432, 7 p.Article

Taurolidine lock : The key to prevention of recurrent catheter-related bloodstream infectionsJUREWITSCH, Brian; JEEJEEBHOY, Khursheed N.Clinical nutrition (Edinburgh). 2005, Vol 24, Num 3, pp 462-465, issn 0261-5614, 4 p.Article

Significant Reduction in Central Venous Catheter―related Bloodstream Infections in Children on HPN After Starting Treatment With Taurolidine Line LockCHU, Hui-Ping; BRIND, Joanne; TOMAR, Rajeev et al.Journal of pediatric gastroenterology and nutrition. 2012, Vol 55, Num 4, pp 403-407, issn 0277-2116, 5 p.Article

Taurolidine is effective in the treatment of central venous catheter-related bloodstream infections in cancer patientsKOLDEHOFF, M; ZAKRZEWSKI, J. L.International journal of antimicrobial agents. 2004, Vol 24, Num 5, pp 491-495, issn 0924-8579, 5 p.Article

Taurolidine and Catheter-related Bloodstream Infection : A Systematic Review of the LiteratureBRADSHAW, Joanne H; PUNTIS, John W. L.Journal of pediatric gastroenterology and nutrition. 2008, Vol 47, Num 2, pp 179-186, issn 0277-2116, 8 p.Article

Taurolidine and povidone-iodine induce different types of cell death in malignant pleural mesotheliomaOPITZ, I; SIGRIST, B; HILLINGER, S et al.Lung cancer. 2007, Vol 56, Num 3, pp 327-336, issn 0169-5002, 10 p.Article

The antibacterial drug taurolidine induces apoptosis by a mitochondrial cytochrome c-dependent mechanismZHIYONG HAN; RIBBIZI, Iole; PANTAZIS, Panayotis et al.Anticancer research. 2002, Vol 22, Num 4, pp 1959-1964, issn 0250-7005, 6 p.Article

Biofilm formation in long-term central venous catheters in children with cancer: a randomized controlled open-labelled trial of taurolidine versus heparinMOLLER HANDRUP, Mette; FUURSTED, Kurt; FUNCH, Peter et al.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 2012, Vol 120, Num 10, pp 794-801, issn 0903-4641, 8 p.Article

The influence of adhesion prophylactic substances and taurolidine/heparin on local recurrence and intraperitoneal tumor growth after laparoscopic-assisted bowel resection of colon carcinoma in a rat modelOPITZ, I; VAN DER VEEN, H. C; BRAUMANN, C et al.Surgical endoscopy. 2003, Vol 17, Num 7, pp 1098-1104, issn 0930-2794, 7 p.Article

Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solutionBETJES, Michiel G. H; VAN AGTEREN, Madelon.Nephrology, dialysis, transplantation (Print). 2004, Vol 19, Num 6, pp 1546-1551, issn 0931-0509, 6 p.Article

Treatment of glioblastoma with intravenous taurolidine. First clinical experienceSTENDEL, Ruediger; PICHT, Thomas; SCHILLING, Andreas et al.Anticancer research. 2004, Vol 24, Num 2C, pp 1143-1147, issn 0250-7005, 5 p.Article

Tunneled Catheters with Taurolidine-Citrate-Heparin Lock Solution Significantly Improve the Inflammatory Profile of Hemodialysis PatientsFONTSERE, Néstor; CARDOZO, Celia; DONATE, Javier et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 7, pp 4180-4184, issn 0066-4804, 5 p.Article

NMR STUDIES AND GC ANALYSIS OF THE ANTIBACTERIAL AGENT TAUROLIDINEKNIGHT BI; SKELLERN GG; SMAIL GA et al.1983; JOURNAL OF PHARMACEUTICAL SCIENCES; ISSN 0022-3549; USA; DA. 1983; VOL. 72; NO 6; PP. 705-707; BIBL. 10 REF.Article

STRUCTURAL INVESTIGATION OF A NEW ORGANIC ANTISEPTIC: TAUROLIDINE - A SPECTROSCOPIC STUDY OF ITS STABILITY AND EQUILIBRIA IN VARIOUS SOLVENTSERB F; FEBVAY N; IMBENOTTE M et al.1982; TALANTA (OXF.); ISSN 0039-9140; GBR; DA. 1982; VOL. 29; NO 11A; PP. 953-958; BIBL. 11 REF.Article

The antiendotoxin agent taurolidine potentially reduces ischemia/ reperfusion injury through its metabolite taurineDODDAKULA, Kishore K; NEARY, Peter M; WANG, Jiang H et al.Surgery. 2010, Vol 148, Num 3, pp 567-572, issn 0039-6060, 6 p.Article

A Randomized Double-Blind Controlled Trial of Taurolidine-Citrate Catheter Locks for the Prevention of Bacteremia in Patients Treated With HemodialysisSOLOMON, Laurie R; CHEESBROUGH, John S; BHAT, Rammohan et al.American journal of kidney diseases. 2010, Vol 55, Num 6, pp 1060-1068, issn 0272-6386, 9 p.Article

Peritoneal instillation of taurolidine or polihexanide modulates intestinal microcirculation in experimental endotoxemiaFRIELING, Helge; LAUER, Kai-Steffen; GRÜNDLING, Matthias et al.International journal of colorectal disease (Print). 2007, Vol 22, Num 7, pp 807-817, issn 0179-1958, 11 p.Article

Hyaluronic acid/carboxymethylcellulose membrane barrier versus taurolidine for the prevention of adhesions to polypropylene meshERPEK, Hakan; TUNCYUREK, Pars; SOYDER, Aykut et al.European surgical research. 2006, Vol 38, Num 4, pp 414-417, issn 0014-312X, 4 p.Article

The antimicrobial activity of Taurolin®. A possible additive for parenteral nutrition solutionsBLENKHARN, J. I.Clinical nutrition (Edinburgh). 1987, Vol 6, Num 1, pp 35-38, issn 0261-5614Article

Absence of microbial adaptation to taurolidine in patients on home parenteral nutrition who develop catheter related bloodstream infections and use taurolidine locksOLTHOF, E. D; RENTENAAR, R. J; RIJS, A. J. M. M et al.Clinical nutrition (Edinburgh). 2013, Vol 32, Num 4, pp 538-542, issn 0261-5614, 5 p.Article

High doses of taurolidine inhibit advanced intraperitoneal tumor growth in ratsBRAUMANN, Chris; STUHLDREIER, Benedikt; BOBRICH, Eva et al.The Journal of surgical research. 2005, Vol 129, Num 1, pp 129-135, issn 0022-4804, 7 p.Article

  • Page / 4